Corvus Pharmaceuticals (CRVS) Superinvestor holders
7 of the superinvestors we track hold Corvus Pharmaceuticals (CRVS) in their latest 13F filings, $32M in total.
Summary
The largest holder is Ken Fisher (Fisher Investments), with $12M, 0.0% of the portfolio.
In their latest quarter: 2 opened a new position, 3 added, 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Ken Fisher Fisher Investments |
New position | 1,040,606 | $12M | 0.0% | Q3 2026 |
| Two Sigma Two Sigma Investments |
Added | 785,208 | $12M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 250,291 | $4M | 0.1% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
New position | 133,177 | $2M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 100,474 | $2M | 0.0% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Added | 56,723 | $847,442 | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 21,992 | $328,560 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 6 |
| Q1 2026 | 8 |
| Q4 2025 | 7 |
| Q3 2025 | 5 |
| Q2 2025 | 5 |
| Q1 2025 | 7 |
| Q4 2024 | 6 |
| Q3 2024 | 6 |
Questions about Corvus Pharmaceuticals
Which superinvestors own Corvus Pharmaceuticals?
7 of the superinvestors we track hold Corvus Pharmaceuticals (CRVS) in their latest 13F filings, $32M in total. Ken Fisher, Two Sigma, Alan Howard, David Shaw, Paul Marshall, Fred DiSanto.
Who is the largest superinvestor holder of CRVS?
The largest holder is Ken Fisher (Fisher Investments), with $12M, 0.0% of the portfolio.
From Corvus Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.